PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pediatric Pharmacology and Pharmacometrics Research Center, University of Basel Children\'s Hospital, Basel, Switzerland.\', \'Department of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.\', \'Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands.\', \'Division of Clinical Pharmacology, Children\'s National Hospital, Washington, DC, USA.\', \'Department of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. c.knibbe@antoniusziekenhuis.nl.\', \'Department of Clinical Pharmacy, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands. c.knibbe@antoniusziekenhuis.nl.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40262-020-00891-1
?:doi
?:hasPublicationType
?:journal
  • Clinical pharmacokinetics
is ?:pmid of
?:pmid
?:pmid
  • 32306288
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.482
?:rankingScore_hIndex
  • 146
is ?:relation_isRelatedTo_publication of
?:title
  • Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all